Pfizer says BNT162b2 vaccine is effective against new Covid strains

Pfizer said that an in vitro study showed that the BNT162b2 vaccine was found to be effective against SARS-CoV-2 virus with the N501Y mutation. (Credit: Coolcaesar/Wikipedia.org)